HG Russnes, C Caldas
Journal name: 
EMBO Mol Med
Citation info: 
Extensive efforts have now characterized the somatic molecular alterations in human breast cancer (Cancer Genome Atlas Network, 2012; Stephens et al, 2012) and have led to a re-definition of the disease as a constellation of 10 distinct driver-based subtypes (IntClust subtypes) (Curtis et al, 2012). The pursuit of druggable targets for each of these subtypes is now pressing. This is elegantly illustrated by the work of Liu et al (2014).
Research group: 
Caldas Group
E-pub date: 
31 Dec 2014
Users with this publication listed: 
Carlos Caldas